CWC
RGEN icon

Carolinas Wealth Consulting’s Repligen RGEN Stock Holding History

Carolinas Wealth Consulting’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-16
Closed -$2.04K – 739
2025
Q1 		$2.04K Buy
16
+1
+7% +$154 ﹤0.01% 798
2024
Q4 		$2.03K Buy
+15
New +$2.15K ﹤0.01% 830
2024
Q1 		– Sell
-10
Closed -$1.8K – 1130
2023
Q4 		$1.8K Hold
10
– – ﹤0.01% 756
2023
Q3 		$1.28K Buy
+10
New +$1.64K ﹤0.01% 791
2020
Q4 		– Sell
-15
Closed -$2K – 1008
2020
Q3 		$2K Buy
+15
New +$2.14K ﹤0.01% 736

Other funds holding RGEN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Carolinas Wealth Consulting's RGEN Position: Q2 2025 in Review

Carolinas Wealth Consulting sold out of Repligen (RGEN) in Q2 2025, closing a stake of 16 shares — an estimated $2.04K sold.

Carolinas Wealth Consulting first reported a position in RGEN in Q3 2020 and held it in 5 quarters. The position peaked at $2.04K in Q1 2025. 444 funds tracked by Wall St. Rank hold RGEN as of Q2 2025.

  • Carolinas Wealth Consulting reported no remaining Repligen position as of Q2 2025 after selling out during the quarter.
  • Carolinas Wealth Consulting sold 16 Repligen shares in Q2 2025, an estimated $2.04K.
  • Carolinas Wealth Consulting first reported a position in Repligen in Q3 2020 and held it in 5 quarters.
  • Carolinas Wealth Consulting's Repligen position peaked at $2.04K in Q1 2025.
  • 444 funds tracked by Wall St. Rank held Repligen as of Q2 2025.

Based on Carolinas Wealth Consulting's 13F filing for Q2 2025.